S Pampfer
Overview
Explore the profile of S Pampfer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinck L, Thissen J, Pampfer S, de Hertogh R
Diabetologia
. 2003 Mar;
46(2):276-83.
PMID: 12627327
Aims/hypothesis: Previous studies have shown that diabetic placentas are characterized by structural and biochemical anomalies, including defects in the differentiation of trophoblasts. In this study, the Rcho-1 cell line was...
2.
Donnay I, Feugang J, Bernard S, Marchandise J, Pampfer S, Moens A, et al.
Zygote
. 2002 Sep;
10(3):189-99.
PMID: 12214799
Although toxic for early stages of embryo development, glucose is a physiological metabolic substrate at the morula and blastocyst stages. We evaluated the effect of adding 5.5 mM glucose from...
3.
Genicot G, Donnay I, Pampfer S, de Hertogh R
Diabetologia
. 2002 May;
45(4):571-9.
PMID: 12032635
Aims/hypothesis: Signs of apoptosis have been observed in rodent blastocysts exposed to high d-glucose concentrations in vitro. The mechanism underlying the detrimental influence of glucose remains to be identified. It...
4.
de Hertogh R, Pampfer S
Diabetologia
. 2001 Nov;
44(10):1318-25.
PMID: 11692181
Aims/hypothesis: Paracrine interactions are thought to operate between the inner cell mass and trophectoderm cell lineages to co-ordinate their expansion and differentiation during embryo implantation. We aimed to determine whether...
5.
de Hertogh R, Pampfer S
Mol Reprod Dev
. 2001 Sep;
60(1):38-46.
PMID: 11550266
Previous studies have suggested that fibroblast growth factor-4 (FGF-4) may be a paracrine signal used by inner cell mass (ICM) cells to maintain adjacent trophectoderm (TE) cells in an undifferentiated...
6.
Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C
Mol Hum Reprod
. 2001 Jul;
7(8):765-70.
PMID: 11470864
Vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) are considered to play important roles in angiogenesis and vascular permeability during placental development. Since trisomy 21 placentae show trophoblastic...
7.
Pampfer S
Am J Reprod Immunol
. 2001 Jul;
45(6):375-81.
PMID: 11458880
Insulin-dependent (type I) diabetes is an auto-immune disorder that produces secondary complications in numerous non-immunological systems. Changes in the synthesis and action pattern of several cytokines have been associated with...
8.
Inhibin subunits mRNA expression level in human placenta from normal and Down's syndrome pregnancies
Debieve F, Pampfer S, Thomas K
Placenta
. 2001 Feb;
22(1):96-102.
PMID: 11162358
In order to study the mechanisms leading to increased inhibin A and activin A in maternal serum with advancing gestation and increased inhibin A in Down's syndrome pregnancy, the mRNA...
9.
Hinck L, Van Der Smissen P, Heusterpreute M, Donnay I, de Hertogh R, Pampfer S
Biol Reprod
. 2001 Feb;
64(2):555-62.
PMID: 11159358
Previous investigations have shown that maternal diabetes impairs rodent embryo development during the earliest phase of gestation. Exposure to high concentrations of glucose before implantation results in a decrease in...
10.
Pampfer S, Cordi S, Vanderheyden I, Van Der Smissen P, Courtoy P, van Cauwenberge A, et al.
Diabetes
. 2001 Jan;
50(1):143-9.
PMID: 11147780
Bcl-2 mRNA expression was detected in rat blastocysts by in situ hybridization. The distribution of mRNA expression was rather heterogenous, with approximately 2% of high-expressing cells. In vitro exposure to...